Donor requirements for regulatory T cell suppression of murine graft-versus-host disease

Journal of Immunology

Volumn 195, Issue 1, 2015, Pages 347-355

  Pierini, Antonio ^a   Colonna, Lucrezia ^b   Alvarez, Maite ^a   Schneidawind, Dominik ^a   Nishikii, Hidekazu ^a   Baker, Jeanette ^a   Pan, Yuqiong ^a   Florek, Mareike ^a   Kim, Byung Su ^a   Negrin, Robert S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA;

ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DONOR; GENE EXPRESSION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; PATHOLOGY; TRANSPLANTATION; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ANIMALS; BIOMARKERS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 84932090148     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402861     Document Type: Article

References (43)

1. Ferrara, J. L., and H. J. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324: 667-674.
2. Jones, S. C., G. F. Murphy, and R. Korngold. 2003. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol. Blood Marrow Transplant. 9: 243-256.
3. Cohen, J. L., A. Trenado, D. Vasey, D. Klatzmann, and B. L. Salomon. 2002. CD4+CD25+ immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196: 401-406.
4. Edinger, M., P. Hoffmann, J. Ermann, K. Drago, C. G. Fathman, S. Strober, and R. S. Negrin. 2003. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9: 1144-1150.
5. Hoffmann, P., J. Ermann, M. Edinger, C. G. Fathman, and S. Strober. 2002. Donortype CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196: 389-399.
6. Taylor, P. A., C. J. Lees, and B. R. Blazar. 2002. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versushost disease lethality. Blood 99: 3493-3499.
7. Di Ianni, M., F. Falzetti, A. Carotti, A. Terenzi, F. Castellino, E. Bonifacio, B. Del Papa, T. Zei, R. I. Ostini, D. Cecchini, et al. 2011. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117: 3921-3928.
8. Martelli, M. F., M. Di Ianni, L. Ruggeri, F. Falzetti, A. Carotti, A. Terenzi, A. Pierini, M. S. Massei, L. Amico, E. Urbani, et al. 2014. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood 124: 638-644.
9. Brunstein, C. G., J. S. Miller, Q. Cao, D. H. McKenna, K. L. Hippen, J. Curtsinger, T. Defor, B. L. Levine, C. H. June, P. Rubinstein, et al. 2011. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117: 1061-1070.
10. Koreth, J., K. Matsuoka, H. T. Kim, S. M. McDonough, B. Bindra, E. P. Alyea, III, P. Armand, C. Cutler, V. T. Ho, N. S. Treister, et al. 2011. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365: 2055-2066.
11. Martelli, M. F., M. Di Ianni, L. Ruggeri, A. Pierini, F. Falzetti, A. Carotti, A. Terenzi, Y. Reisner, F. Aversa, B. Falini, and A. Velardi. 2014. "Designed" grafts for HLA-haploidentical stem cell transplantation. Blood 123: 967-973.
12. Schneidawind, D., A. Pierini, and R. S. Negrin. 2013. Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation. Blood 122: 3116-3121.
13. Campbell, D. J., and M. A. Koch. 2011. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11: 119-130.
14. Colonna, L., E. I. Sega, and R. S. Negrin. 2011. Natural and expanded CD4+ CD25+ regulatory T cells in bone marrow transplantation. Biol. Blood Marrow Transplant. 17(1 Suppl.): S58-S62.
15. Nguyen, V. H., R. Zeiser, D. L. Dasilva, D. S. Chang, A. Beilhack, C. H. Contag, and R. S. Negrin. 2007. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 109: 2649-2656.
16. Ermann, J., P. Hoffmann, M. Edinger, S. Dutt, F. G. Blankenberg, J. P. Higgins, R. S. Negrin, C. G. Fathman, and S. Strober. 2005. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 105: 2220-2226.
17. Hoffmann, P., R. Eder, L. A. Kunz-Schughart, R. Andreesen, and M. Edinger. 2004. Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells. Blood 104: 895-903.
18. Levings, M. K., R. Sangregorio, and M. G. Roncarolo. 2001. Human Cd25+Cd4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
19. Veerapathran, A., J. Pidala, F. Beato, B. Betts, J. Kim, J. G. Turner, M. K. Hellerstein, X. Z. Yu, W. Janssen, and C. Anasetti. 2013. Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease. Blood 122: 2251-2261.
20. Veerapathran, A., J. Pidala, F. Beato, X. Z. Yu, and C. Anasetti. 2011. Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. Blood 118: 5671-5680.
21. Cao, Y. A., A. J. Wagers, A. Beilhack, J. Dusich, M. H. Bachmann, R. S. Negrin, I. L. Weissman, and C. H. Contag. 2004. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. USA 101: 221-226.
22. Edinger, M., Y. A. Cao, M. R. Verneris, M. H. Bachmann, C. H. Contag, and R. S. Negrin. 2003. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101: 640-648.
23. Cooke, K. R., L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte, Jr., J. M. Crawford, and J. L. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239.
24. Huang, C. T., C. J. Workman, D. Flies, X. Pan, A. L. Marson, G. Zhou, E. L. Hipkiss, S. Ravi, J. Kowalski, H. I. Levitsky, et al. 2004. Role of LAG-3 in regulatory T cells. Immunity 21: 503-513.
25. Sega, E. I., D. B. Leveson-Gower, M. Florek, D. Schneidawind, R. H. Luong, and R. S. Negrin. 2014. Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation. PLoS ONE 9: e86551.
26. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
27. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
28. Shin, H. J., J. Baker, D. B. Leveson-Gower, A. T. Smith, E. I. Sega, and R. S. Negrin. 2011. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 118: 2342-2350.
29. Nguyen, V. H., S. Shashidhar, D. S. Chang, L. Ho, N. Kambham, M. Bachmann, J. M. Brown, and R. S. Negrin. 2008. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111: 945-953.
30. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272: 60-66.
31. Beilhack, A., S. Schulz, J. Baker, G. F. Beilhack, C. B. Wieland, E. I. Herman, E. M. Baker, Y. A. Cao, C. H. Contag, and R. S. Negrin. 2005. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106: 1113-1122.
32. Korngold, R., and P. J. Wettstein. 1990. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J. Immunol. 145: 4079-4088.
33. Sun, K., M. Alvarez, E. Ames, I. Barao, M. Chen, D. L. Longo, D. Redelman, and W. J. Murphy. 2012. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood 119: 1590-1598.
34. Duffner, U. A., Y. Maeda, K. R. Cooke, P. Reddy, R. Ordemann, C. Liu, J. L. Ferrara, and T. Teshima. 2004. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J. Immunol. 172: 7393-7398.
35. Matte, C. C., J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W. D. Shlomchik. 2004. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10: 987-992.
36. Reddy, P., Y. Maeda, C. Liu, O. I. Krijanovski, R. Korngold, and J. L. Ferrara. 2005. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat. Med. 11: 1244-1249.
37. Wang, X. N., M. A. Haniffa, U. Holtick, M. P. Collin, G. Jackson, C. M. Hilkens, E. Holler, M. Edinger, P. Hoffmann, and A. M. Dickinson. 2009. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Transplantation 88: 188-197.
38. Lin, K. L., L. M. Fulton, M. Berginski, M. L. West, N. A. Taylor, T. P. Moran, J. M. Coghill, B. R. Blazar, J. E. Bear, and J. S. Serody. 2014. Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD. Blood 123: 1604-1614.
39. Matsuoka, K., J. Koreth, H. T. Kim, G. Bascug, S. McDonough, Y. Kawano, K. Murase, C. Cutler, V. T. Ho, E. P. Alyea, et al. 2013. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graftversus-host disease. Sci. Transl. Med. 5: 179ra143.
40. Martin, G. H., S. Grégoire, D. A. Landau, C. Pilon, Y. Grinberg-Bleyer, F. Charlotte, J. P. Mège, L. Chatenoud, B. L. Salomon, and J. L. Cohen. 2013. In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice. Eur. J. Immunol. 43: 2263-2272.
41. Chopra, M., S. S. Riedel, M. Biehl, S. Krieger, V. von Krosigk, C. A. Bäuerlein, C. Brede, A. L. Jordan Garrote, S. Kraus, V. Schäfer, et al. 2013. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis. Carcinogenesis 34: 1296-1303.
42. Reddy, P., R. Negrin, and G. R. Hill. 2008. Mouse models of bone marrow transplantation. Biol. Blood Marrow Transplant. 14: 129-135.
43. Steiner, D., N. Brunicki, B. R. Blazar, E. Bachar-Lustig, and Y. Reisner. 2006. Tolerance induction by third-party "off-the-shelf" CD4+CD25+ Treg cells. Exp. Hematol. 34: 66-71.